Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$660M |
| 2 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$173M |
| 3 |
Altria Group
MO
|
+$145M |
| 4 |
Verizon
VZ
|
+$134M |
| 5 |
United Parcel Service
UPS
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
|
+$181M |
| 2 |
iShares MSCI Germany ETF
EWG
|
+$148M |
| 3 |
Apple
AAPL
|
+$127M |
| 4 |
abrdn Physical Gold Shares ETF
SGOL
|
+$106M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$92.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.3% |
| 2 | Financials | 12.48% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 11.3% |
| 5 | Industrials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IVC
2326
DELISTED
Invacare Corporation
IVC
| $4.05M | ﹤0.01% |
452,448
+3,782
| +0.8% | +$31.4K |
|
2327
MGP Ingredients
MGPI
$366M
| $4.05M | ﹤0.01% |
86,035
+260
| +0.3% | +$11.2K |
|
|
BMTC
2328
DELISTED
Bryn Mawr Bank Corp
BMTC
| $4.03M | ﹤0.01% |
131,623
+2,051
| +2% | +$59.9K |
|
2329
MiMedx Group
MDXG
$622M
| $4.01M | ﹤0.01% |
+441,944
| New | +$3.18M |
|
|
IGMS
2330
DELISTED
IGM Biosciences
IGMS
| $4.01M | ﹤0.01% |
45,379
-538
| -1% | -$37.8K |
|
2331
Origin Bancorp
OBK
$1.7B
| $4M | ﹤0.01% |
143,908
+527
| +0.4% | +$13.4K |
|
|
NGM
2332
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $3.98M | ﹤0.01% |
131,499
+1,839
| +1% | +$40.2K |
|
2333
Arcutis Biotherapeutics
ARQT
$3.26B
| $3.98M | ﹤0.01% |
141,439
+30,816
| +28% | +$755K |
|
2334
Univest Financial
UVSP
$1.24B
| $3.98M | ﹤0.01% |
193,165
+500
| +0.3% | +$8.96K |
|
2335
York Water
YORW
$502M
| $3.97M | ﹤0.01% |
85,114
+316
| +0.4% | +$14.5K |
|
2336
Gorman-Rupp
GRC
$2.26B
| $3.96M | ﹤0.01% |
121,910
+1,950
| +2% | +$64.6K |
|
2337
Nicolet Bankshares
NIC
$3.67B
| $3.94M | ﹤0.01% |
59,453
-354
| -0.6% | -$23.1K |
|
2338
Keros Therapeutics
KROS
$203M
| $3.93M | ﹤0.01% |
55,733
+11,884
| +27% | +$749K |
|
2339
Utz Brands
UTZ
$1.25B
| $3.92M | ﹤0.01% |
+177,432
| New | +$3.37M |
|
2340
Digimarc Corp
DMRC
$166M
| $3.89M | ﹤0.01% |
82,393
+887
| +1% | +$34.7K |
|
|
NFBK
2341
DELISTED
Northfield Bancorp
NFBK
| $3.89M | ﹤0.01% |
315,517
+5,941
| +2% | +$65.9K |
|
2342
The RMR Group
RMR
$325M
| $3.89M | ﹤0.01% |
100,734
+240
| +0.2% | +$7.89K |
|
|
NPTN
2343
DELISTED
NEOPHOTONICS CORP
NPTN
| $3.89M | ﹤0.01% |
427,586
-134,613
| -24% | -$1.04M |
|
|
SRDX
2344
DELISTED
Surmodics
SRDX
| $3.87M | ﹤0.01% |
89,012
+1,137
| +1% | +$44.8K |
|
|
JAMF
2345
DELISTED
Jamf
JAMF
| $3.87M | ﹤0.01% |
129,158
+51,063
| +65% | +$1.68M |
|
|
VBIV
2346
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $3.86M | ﹤0.01% |
46,746
+2,084
| +5% | +$178K |
|
|
AERI
2347
DELISTED
Aerie Pharmaceuticals
AERI
| $3.85M | ﹤0.01% |
284,856
+2,767
| +1% | +$33.4K |
|
2348
Praxis Precision Medicines
PRAX
$8.64B
| $3.84M | ﹤0.01% |
+4,651
| New | +$2.71M |
|
2349
AngioDynamics
ANGO
$628M
| $3.81M | ﹤0.01% |
248,387
+6,013
| +2% | +$76.3K |
|
2350
Kymera Therapeutics
KYMR
$8.59B
| $3.8M | ﹤0.01% |
+61,334
| New | +$2.99M |
|
Similar funds
Charles Schwab's Q4 2020 Portfolio in Review
As of Q4 2020, Charles Schwab held 3,457 positions worth $252B, up 16% from $217B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q4 2020 filing shows 113 new, 2,243 increased, 711 reduced and 62 closed positions. Its largest new stake was Vanguard FTSE Pacific ETF: 993,047 shares worth $79M. The largest sale was VanEck JP Morgan EM Local Currency Bond ETF, an estimated $181M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2020 buy was Vanguard FTSE Pacific ETF: 993,047 shares worth $79M.
- Charles Schwab added most to Tesla in Q4 2020, an estimated $660M increase.
- Charles Schwab's biggest Q4 2020 reduction was VanEck JP Morgan EM Local Currency Bond ETF, cutting an estimated $181M.
- Charles Schwab fully exited iShares MSCI Germany ETF in Q4 2020, selling an estimated $148M.
- Charles Schwab's ten largest holdings make up 17% of its $252B portfolio in Q4 2020.
- Charles Schwab opened 113 new positions and closed 62 in Q4 2020.
- Charles Schwab's portfolio value rose 16% quarter-over-quarter to $252B.
Based on Charles Schwab's 13F filing for Q4 2020, filed 16 Feb 2021.